Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Respiratory infection

Original research

Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia

Online download statistics by month:

Online download statistics by month: January 2021 to July 2022

	Abstract	Full	Pdf
Jan 2021	456	17	10
Feb 2021	1252	93	63
Mar 2021	538	51	35
Apr 2021	665	57	36
May 2021	358	47	38
Jun 2021	49	38	28
Jul 2021	44	37	13
Aug 2021	38	27	18
Sep 2021	41	30	11
Oct 2021	427	17	17
Nov 2021	433	14	6
Dec 2021	140	5	0
Jan 2022	217	10	7
Feb 2022	337	12	9
Mar 2022	260	8	4
Apr 2022	196	7	5
May 2022	166	12	6
Jun 2022	220	11	10
Jul 2022	220	8	9
Total	6057	501	325